COMMENT	O
:	O
A	O
high	O
percentage	O
of	O
tumor	O
cells	O
(	O
greater	O
than	O
20	O
%	O
)	O
immunostaining	O
for	O
MGMT	O
has	O
been	O
reported	O
to	O
be	O
associated	O
.	O
with	O
a	O
relatively	O
diminished	O
response	O
to	O
Temodar	O
.	O
